1. Alexopoulos, CG, Vaslamatzis, M, Zoublios, C & Chatzidimitriou, G (1992). Reactivation of hepatitis B in HBsAg carriers during cancer chemotherapy. Ann Oncol 3: 65
2. Alexopoulos, CG, Vaslamatzis, M & Chatzidimitriou, G (1997). Incidence of hepatitis B virus (HBV) positivity and behaviour of hepatitis B surface antigen (HBsAg) carrier state in cancer patients, during chemotherapy (CT). Proc Am Soc Clin Oncol 16: A1490
3. Bird, GLA, Smith, H, Portmann, B, Alexander, GJM & Williams, R (1989). Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers. Quart J Med, New Series 73 270: 895–902.
4. Gallbraith, RM, Eddleston, AL, Williams, R, Zucherman, AJ & Bagshaw, KD (1975). Fulminant hepatic failure in leukemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy. Lancet 2: 528–530.
5. Hoofnagle, JH, Dusheiko, GM, Schafer, DF, Jones, EA, Micetich, CK, Young, CR & Costa, J (1982). Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Am Intern Med 96: 447–449.